Changhao Xu

Changhao Xu

Auto-generated profile, based on publicly available information

Changhao Xu

Department of Cardiology, Fujian Medical University Union Hospital, Fujian Cardiovascular Medicine Center, China (C.X.).

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2023 in EP Europace
Verified
Journal Article
Open access
PDF file
KLKaige Li
Kaige Li
CXChanghao Xu
Changhao Xu
XZXiyao Zhu
Xiyao Zhu
XWXinhua Wang
Xinhua Wang
PYPing Ye
Ping Ye
MLMD; Xu Liu
MD; Xu Liu
The optimal strategy for persistent atrial fibrillation (PerAF) is poorly defined. We conducted a multicentre, randomized, prospective trial to compare the outcomes of different ablation strategies for PerAF. We enrolled 450 patients and randomly assigned them in a 1:1:1 ratio to undergo pulmonary vein isolation and subsequently undergo the following three different ablation strategies: anatomical guided ablation (ANAT group, n = 150), electrogram guided ablation (EGM group, n = 150), and extensive electro-anatomical guided ablation (EXT group, n = 150). The primary endpoint was freedom from atrial fibrillation (AF) lasting longer than 30 s at 12 months after a single ablation procedure. After 12 months of follow-up, 72% (108) of patients in the EXT group were free from AF recurrence, as compared with the 64% (96) in the EGM group (P = 0.116), and 54% (81) in the ANAT group (P = 0.002). The EXT group showed less AF/atrial tachycardia recurrence than the EGM group (60% vs. 50%, P = 0.064) and the ANAT group (60% vs. 37.3%, P < 0.001). The EXT group showed the highest rate of AF termination (66.7%), followed by 56.7% in the EGM group, and 20.7% in the ANAT group. The AF termination signified less AF recurrence at 12 months compared to patients without AF termination (30.1% vs. 42.7%, P = 0.008). Safety endpoints did not differ significantly between the three groups (P = 0.924). Electro-anatomical guided ablation achieved the most favourable outcomes among the three ablation strategies. The AF termination is a reliable ablation endpoint. Extensive electro-anatomical guided ablation for persistent atrial fibrillation.

3 February 2023 in EP Europace
Verified
Journal Article
Open access
PDF file
CXChang-Hao Xu
Chang-Hao Xu
FXFeng Xiong
Feng Xiong
WJWei-Feng Jiang
Wei-Feng Jiang
MLMD; Xu Liu
MD; Xu Liu
TLTao Liu
Tao Liu
MQMu Qin
Mu Qin
Treatment of atrial fibrillation (AF) remains challenging despite significant progress in understanding its underlying mechanisms. The first detailed, quantitative theory of functional re-entry, the ‘leading circle’ model, was developed more than 40 years ago. Subsequently, in decades of study, an alternative paradigm based on spiral waves has long been postulated to drive AF. The rotor as a ‘spiral wave generator’ is a curved ‘vortex’ formed by spin motion in the two-dimensional plane, identified using advanced mapping methods in experimental and clinical AF. However, it is challenging to achieve complementary results between experimental results and clinical studies due to the limitation in research methods and the complexity of the rotor mechanism. Here, we review knowledge garnered over decades on generation, electrophysiological properties, and three-dimensional (3D) structure diversity of the rotor mechanism and make a comparison among recent clinical approaches to identify rotors. Although initial studies of rotor ablation at many independent centres have achieved promising results, some inconclusive outcomes exist in others. We propose that the clinical rotor identification might be substantially influenced by (i) non-identical surface activation patterns, which resulted from a diverse 3D form of scroll wave, and (ii) inadequate resolution of mapping techniques. With rapidly advancing theoretical and technological developments, future work is required to resolve clinically relevant limitations in current basic and clinical research methodology, translate from one to the other, and resolve available mapping techniques.

20 November 2023 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
CXChanghao Xu
Changhao Xu
FZFeng Zhang
Feng Zhang
WCWenbo Chen
Wenbo Chen
NCNannan Chen
Nannan Chen
YZYu Zhang
Yu Zhang
MQMu Qin
Mu Qin

1 September 2023 in medRxiv
Verified
Preprint
Open access
PDF file
CXChanghao Xu
Changhao Xu
KLKaige Li
Kaige Li
XZXiyao Zhu
Xiyao Zhu
XWXin-Hua Wang
Xin-Hua Wang
PYPing Ye
Ping Ye
MLMD; Xu Liu
MD; Xu Liu
Background: Additional linear ablation for persistent atrial fibrillation (PerAF) still has limited evidence-based medical proof. Objectives: We probed into the mechanisms of intermediate atrial tachycardia (AT) during PerAF termination by catheter ablation and provided evidence for it. Methods: 136 patients who converted to organized AT after PerAF termination in the Extent-AF study were analyzed. Bi-atrial activation mapping combined with entrainment mapping were performed to identify the mechanisms and critical isthmus of these ATs. Results: A total of 164 ATs in 136 patients were identified (average 1.2 per patients) and 143 (87%) ATs in 113 patients (average 1.3 per patient) were successfully mapped. The mechanisms of intermediate ATs were macro-reentry in 110 (77%), micro-reentry in 21 (15%), and focal AT in 12 (8%). Among the macro-reentrant ATs, the most common were perimitral ATs (PM-AT) 52 (47%), followed by roof dependent ATs (RF-AT) in 40 (36%) and typical atrial flutter (AFL) in 18 (16%). 98 (72%) patients had successfully ablated intermediate ATs. Among these patients, 88 (90%) required at least one of the perimitral line, roofline, or peritricuspid line to finally restore sinus rhythm. At the end of 12 months of follow-up, 63 (64.3%) patients with successful ablative ATs were free of any arrhythmia. Conclusion: The majority of intermediate ATs after PerAF termination were macro-reentrant ATs. Linear ablation targets the mitral isthmus, roof, and tricuspid isthmus was a critical step of PerAF ablation to restore sinus rhythm in up to 90% patients, suggesting the importance of additional linear ablation.

1 April 2026 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
KLKaige Li
Kaige Li
XWXinhua Wang
Xinhua Wang
MQMu Qin
Mu Qin
PYPing Ye
Ping Ye
BHBing Han
Bing Han
XHXumin Hou
Xumin Hou
BACKGROUND: Catheter ablation has been shown to improve prognosis in patients with heart failure (HF) and atrial fibrillation (AF); however, the optimal ablation strategy remains undefined. METHODS: In this multicenter, randomized controlled trial, 300 patients with persistent AF and HF, including both HF with reduced ejection fraction (ejection fraction ≤40%) and HF with preserved ejection fraction (ejection fraction >40%, including mid-range ejection fraction [ejection fraction 41% to 50%]), were enrolled and randomized equally to the anatomic-guided ablation, electrogram-guided ablation, and extensive electrogram-anatomic–guided ablation groups, with 100 patients in each group. The coprimary end points were: (1) the composite of cardiovascular death or HF-related hospitalization/urgent visit within 36 months; and (2) maintenance of sinus rhythm at 36 months. Secondary end points included AF burden <1%, New York Heart Association class improvement (≥1 grade), 6-minute walk test change, NT-proBNP (N-terminal pro-B-type natriuretic peptide) reduction, and procedure-related complications. Subgroup analyses were performed for HF with reduced ejection fraction and HF with preserved ejection fraction. RESULTS: At 36 months, the extensive electro-anatomic–guided ablation group demonstrated the lowest incidence of the composite end point (17.0%) compared with the electrogram-guided ablation (29.0%) and anatomic-guided ablation (36.0%; overall P =0.010) groups, and the highest rate of sinus rhythm maintenance (62.0%) compared with the electrogram-guided ablation (53.0%) and anatomic-guided ablation (44.0%; P =0.039) groups. Consistent improvements were observed for AF burden <1%, New York Heart Association class, 6-minute walk test, and NT-proBNP. Major complications were low and similar across all groups. These trends were consistent in both the HF with reduced ejection fraction and HF with preserved ejection fraction subgroups. CONCLUSIONS: Electrogram-anatomic ablation provides superior long-term rhythm control, reduces cardiovascular events, and improves symptoms in patients with persistent AF and HF, regardless of ejection fraction. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT07153718.